Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 62 for

Edit search filters
  1. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis

    Jacksonville, FL

  2. Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  3. HEALEY ALS Platform Trial

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  4. A Study To Assess FLX-787 In Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

    Jacksonville, FL

  5. A Study For Patients Who Completed VITALITY-ALS (CY 4031) VIGOR-ALS

    Jacksonville, FL

  6. Effects Of Oral Levosimendan (ODM-109) On Respiratory Function In Patients With ALS

    Jacksonville, FL

  7. A Study of the Effect of Ezogabine on Motor Neuron Excitability in Patients with Amyotrophic Lateral Sclerosis

    Jacksonville, FL

  8. A Study To Evaluate Efficacy, Safety And Tolerability Of CK-2127107 In Patients With Amyotrophic Lateral Sclerosis (ALS)

    Rochester, MN

  9. A Study Of The Safety And Effectiveness Of NP001 For Patients With Amyotrophic Lateral Sclerosis (ALS) And Systemic Inflammation

    Jacksonville, FL

  10. A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients

    Jacksonville, FL

.

Mayo Clinic Footer